Matches in Nanopublications for { ?s ?p ?o <http://www.tkuhn.ch/bel2nanopub/RAcx3g223emU-UgJbu_LIC6dgwpeKiax-AD5Xt4nL49ps#provenance>. }
Showing items 1 to 11 of
11
with 100 items per page.
- _5 label "Selventa" provenance.
- large_corpus.bel title "BEL Framework Large Corpus Document" provenance.
- large_corpus.bel description "Approximately 61,000 statements." provenance.
- large_corpus.bel version "20131211" provenance.
- large_corpus.bel authoredBy _5 provenance.
- assertion wasDerivedFrom large_corpus.bel provenance.
- assertion wasDerivedFrom _4 provenance.
- assertion hadPrimarySource 12154350 provenance.
- _4 wasQuotedFrom 12154350 provenance.
- _4 value "Consistent with this theory, the vascular effects of VEGFC in experimental tumours were reduced when the mice were treated with blocking antibodies against Vegfr2 (REF. 75). On the basis of these observations, tumour-vessel formation can be dissected into pathways that preferentially activate angiogenesis (driven by VEGFR2) and pathways that preferentially activate lymphangiogenesis (driven by VEGFR3), although there is evidence that the receptors share overlapping expression patterns56." provenance.
- large_corpus.bel rights "Copyright (c) 2011-2012, Selventa. All rights reserved." provenance.